Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00216164
Status:
TERMINATED
Last Update Posted:
2011-05-02
First Post:
2005-09-12
Brief Title:
Rituximab and Gemcitabine for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Sponsor:
Hoosier Cancer Research Network
Organization:
Hoosier Cancer Research Network
Organization Data
Organization:
Hoosier Cancer Research Network
Class:
OTHER
Study ID:
HOG LYM03-64
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hoosier Cancer Research Network
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Michael Robertson MD
Old Organization:
Hoosier Oncology Group
Collaborators
| Name | Class |
|---|---|
| Walther Cancer Institute | OTHER |
| Eli Lilly and Company | INDUSTRY |